A meta-analysis of the therapeutic effect of gefitinib combined with chemotherapy and chemotherapy alone in treating non-small cell lung cancer

BACKGROUND: Whether the combination of gefitinib and chemotherapy is beneficial for advanced non-small cell lung cancer (NSCLC) remains controversial. This study aimed to summarize the currently available evidence and compare the efficacy and safety of gefitinib combined with chemotherapy versus che...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhao, Qingda, Sun, Kai, Lei, Xuemei, Cai, Le
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2020
Materias:
4700
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7402902/
https://www.ncbi.nlm.nih.gov/pubmed/32756179
http://dx.doi.org/10.1097/MD.0000000000021490

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7402902/
https://www.ncbi.nlm.nih.gov/pubmed/32756179
http://dx.doi.org/10.1097/MD.0000000000021490

Ejemplares similares